Agomab Therapeutics Nv (AGMB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AGMB Annual Balance Sheets →
The balance sheet data below highlights changes in Agomab Therapeutics Nv's financial position over recent quarters.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AGMB/balance-sheets
https://api.csimarket.com/api/v1/companies/AGMB/fundamentals
https://api.csimarket.com/api/v1/companies/AGMB/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0
Assets
Cash And Cash Equivalents96.79
Cash & Short-term Investments96.00
Other Current Assets39.00
Total Current Assets135.79
Equipment/Property/Plant Net0.56
Goodwill net9.65
Other Assets, Noncurrent26.16
Total Assets172.15
Liabilities
Other Liabilities, Current20.82
Total Current Liabilities20.82
Total Long-term Debt0.00
Other liabilities, Noncurrent4.72
Total Liabilities25.54
Stockholders' Equity
Other Equity146.61
Common Stockholder's Equity146.61
Total Stockholder's Equity146.61
Liabilities & Stockholder's Equity172.15
4 historic quarters locked

Sign in to unlock the full Agomab Therapeutics Nv balance sheet history.

About Agomab Therapeutics Nv Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-047872

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI